Straits Times Index
3,323.20 -6.89 (-0.21%) S&P 500
5,306.04 +1.32 (+0.02%) Dow
38,852.86 -216.74 (-0.55%) Nasdaq
17,019.88 +99.08 (+0.59%) Bitcoin USD
67,847.42 -674.53 (-0.98%) CMC Crypto 200
1,462.66 -22.03 (-1.48%)
TGTX Aug 2024 9.000 call
| Previous close | 7.72 |
| Open | N/A |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 9.00 |
| Expiry date | 2024-08-16 |
| Day's range | 7.72 - 7.72 |
| Contract range | N/A |
| Volume | |
| Open interest | 10 |
GlobeNewswireTG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of upcoming presentations highlighting study designs for post-marketing studies being undertaken for BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the 2024 Consortium of Multiple Sclerosis Centers (CMSC) annual meeting, being held May 29 – June 1, 2024, in Nashville, Tennessee. Abstracts are now available online and can be accessed on the CM
Insider MonkeyTG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2024 Earnings Call Transcript
TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2024 Earnings Call Transcript May 2, 2024 TG Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to the TG Therapeutics Conference Call and Webcast. At this time all participants are […]
Simply Wall St.Rainbows and Unicorns: TG Therapeutics, Inc. (NASDAQ:TGTX) Analysts Just Became A Lot More Optimistic
TG Therapeutics, Inc. ( NASDAQ:TGTX ) shareholders will have a reason to smile today, with the analysts making...
